Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive phase II results with RMP-7/carboplatin

Dec. 19, 1996

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Chemopreventive effects of Targretin in breast cancer

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

CAK1 gene for treatment and diagnosis of cancers available for licensing

Dec. 17, 1996

SuperGen licenses metalloorganic compounds

Dec. 17, 1996

Angiogenesis inhibitors under study at ADIR

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 31, 2025
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...
Novo weight-loss data roll out; Veru ‘leans’ in
BioWorld
As investors look ahead to data shortly from Veru Inc. with enobosarm, the weight-loss space remains hot, with Novo Nordisk A/S reporting favorable top-line...
Appointments and advancements for Jan. 29, 2025
BioWorld
New hires and promotions in the biopharma industry, including: Allogene, Alumis, Beximco, Clarametyx, Commit, Concerto, OS Therapies, Precision, Roche, Scholar Rock.